Tanvex BioPharma Enters Exclusive Distribution Agreement for Nypozi (filgrastim) in Canada May.16,2023 Jul.08,2024 TX05 BLA resubmisson Read More Oct.04,2021 FDA Accepts TX05 BLA Filing Read More Jul.01,2024 Tanvex received BLA approval from FDA Read More